참고문헌
- Caronia D, Patino-Garcia A, Milne RL, et al (2009). Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients. Pharmacogenomics J, 9, 347-53. https://doi.org/10.1038/tpj.2009.19
- Fuchs B, Zhang K, Schabel A, et al (2001). Identification of twenty-two candidate markers for human osteogenic sarcoma. Gene, 278, 245-52. https://doi.org/10.1016/S0378-1119(01)00731-4
- Goode EL, Ulrich CM, Potter JD (2002). Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev, 11, 1513-30.
- Hao T, Feng W, Zhang J, Sun YJ, Wang G (2012). Association of Four ERCC1 and ERCC2 SNPs with Survival of Bone Tumour Patients. Asian Pac J Cancer Prev, 13, 3821-4. https://doi.org/10.7314/APJCP.2012.13.8.3821
- Hengstler JG, Arand M, Herrero ME, et al (1998). Polymorphisms of N-acetyltransferases, glutathione S-transferases, microsomal epoxide hydrolase, and sulfotransferases: influence on cancer susceptibility. Recent Results Cancer Res, 154, 47-85. https://doi.org/10.1007/978-3-642-46870-4_4
- Ketterer B (1988). The protective role of glutathione transferases in mutagenesis and carcinogenesis. Mutat Res, 202, 343-61. https://doi.org/10.1016/0027-5107(88)90197-2
- Kweekel DM, Gelderblom H, Antonini NF, et al (2009). Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients. Eur J Cancer, 45, 572-8. https://doi.org/10.1016/j.ejca.2008.10.015
- Mirabello L, Troisi RJ, Savage SA (2009). International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons. Int J Cancer, 125, 229-234. https://doi.org/10.1002/ijc.24320
- Pasello M, Manara MC, Michelacci F, et al (2011). Targeting glutathione-S transferase enzymes in musculoskeletal sarcomas: a promising therapeutic strategy. Anal Cell Pathol (Amst), 34, 131-45. https://doi.org/10.1155/2011/414985
- Pasello M, Michelacci F, Scionti I, et al (2008). Overcoming glutathione S-transferase P1-related cisplatin resistance in osteosarcoma. Cancer Res, 68, 6661-8. https://doi.org/10.1158/0008-5472.CAN-07-5840
- Riddick DS, Lee C, Ramji S, et al (2005). Cancer chemotherapy and drug metabolism. Drug Metab Dispos, 33, 1083-96. https://doi.org/10.1124/dmd.105.004374
- Stoehlmacher J, Park DJ, Zhang W, et al (2002). Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer. J Natl Cancer Inst, 94, 936-42. https://doi.org/10.1093/jnci/94.12.936
- U.S. Cancer Statistics Working Group (2009). United States Cancer Statistics: 2004 Incidence and Mortality. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute. Available at: http://www.cdc. gov/cancer/npcr/npcrpdfs/US_Cancer_Statistics_2004_Incidence_and_Mortality.pdf. Oct. 2011.
- Windsor RE, Strauss SJ, Kallis C, et al (2012). Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study. Cancer, 118, 1856-67. https://doi.org/10.1002/cncr.26472
- Wang X, Zuckerman B, Pearson C, et al (2002). Maternal cigarette smoking, metabolic gene polymorphism, and infant birth weight. JAMA, 287, 195-202. https://doi.org/10.1001/jama.287.2.195
- Zhang SL, Mao NF, Sun JY, Shi ZC, Wang B, Sun YJ (2012). Predictive potential of glutathione S-transferase polymorphisms for prognosis of osteosarcoma patients on chemotherapy. Asian Pac J Cancer Prev, 13, 2705-9. https://doi.org/10.7314/APJCP.2012.13.6.2705
- Zimniak P, Nanduri B, Pikula S, et al (1994). Naturally occurring human glutathione S-transferase GSTP-1 isoforms with isoleucin and valine in position 104 differ in enzymic properties. Eur J Biochem, 224, 893-9. https://doi.org/10.1111/j.1432-1033.1994.00893.x
피인용 문헌
- The association of glutathione S-transferase polymorphisms in patients with osteosarcoma: evidence from a meta-analysis vol.24, pp.3, 2014, https://doi.org/10.1111/ecc.12197
- ERCC polymorphisms and prognosis of patients with osteosarcoma vol.35, pp.10, 2014, https://doi.org/10.1007/s13277-014-2322-1
- Predictive potential of ABCB1, ABCC3, and GSTP1 gene polymorphisms on osteosarcoma survival after chemotherapy vol.35, pp.10, 2014, https://doi.org/10.1007/s13277-014-1917-x
- Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy vol.35, pp.4, 2014, https://doi.org/10.1007/s13277-013-1378-7
- Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy? vol.5, pp.1664-8021, 2014, https://doi.org/10.3389/fgene.2014.00391
- Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma vol.11, pp.9, 2015, https://doi.org/10.1517/17425255.2015.1060220
- Translesion Polymerase Genes Polymorphisms and Haplotypes Influence Survival of Osteosarcoma Patients vol.19, pp.3, 2015, https://doi.org/10.1089/omi.2014.0159
- Research progress on the multidrug resistance mechanisms of osteosarcoma chemotherapy and reversal vol.36, pp.3, 2015, https://doi.org/10.1007/s13277-015-3181-0
- Genetic variations in the PRKCG gene and osteosarcoma risk in a Chinese population: a case-control study vol.36, pp.7, 2015, https://doi.org/10.1007/s13277-015-3182-z
- Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis vol.15, pp.1, 2017, https://doi.org/10.1186/s12957-017-1142-3
- The pharmacogenomics of osteosarcoma vol.17, pp.1, 2017, https://doi.org/10.1038/tpj.2016.45
- Haplotype analysis on relationship of ERCC2 and ERCC3 gene polymorphisms with osteosarcoma risk in Chinese young population vol.28, pp.5-6, 2017, https://doi.org/10.1007/s00335-017-9693-8
- Molecular mechanisms of chemoresistance in osteosarcoma (Review) vol.7, pp.5, 2014, https://doi.org/10.3892/ol.2014.1935
- Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy vol.94, pp.39, 2015, https://doi.org/10.1097/MD.0000000000001593